NHS England South West – Patient Group Direction downloads
The new NHS South West region covers the following: Bath and North East Somerset, Swindon, and Wiltshire, Bristol, North Somerset and South Gloucestershire, Cornwall and Isles of Scilly, Devon, Dorset, Gloucestershire and Somerset.
Immunisation by vaccination
Primary to pre-school immunisations
| Diphtheria, Tetanus, Pertussis and Polio – DTaP/IPV (Boostrix®-IPV or Repevax®) |
V5.00 | From 1 November 2023 | Expires 1 November 2025 |
| Diphtheria, Tetanus, Pertussis, Polio, Haemophilus influenzae type b, and hepatitis B – DTaP/IPV/Hib/HepB (Infanrix®-hexa or Vaxelis®) |
V5.00 | From 24 July 2024 | Expires 24 Nov 2026 |
| Haemophilus influenzae type b, and Meningitis C (Menitorix®) |
V5.00 | From 31 July 2022 | Expires 1 August 2024 |
| Haemophilus influenzae type b, and Meningitis C EXTENSION OF VALIDITY (Menitorix®) |
v5.00 | From 31 July 2022 | Expires 31 July 2025 |
| Measles, Mumps, and Rubella – MMR (M-M-RVAXPRO® or Priorix®) |
V5.00 | From 29 February 2024 | Expires 31 January 2027 |
| Meningitis B (Bexsero®) |
V7.00 | From 28 February 2025 | Expires 28 February 2028 |
| Pneumococcal disease (PCV) (Prevenar 13® or Vaxneuvance) |
V5.00 | From 28 February 2024 | Expires 31 May 2026 |
| Rotavirus (Rotarix®) |
V6.00 | From 30 June 2023 | Expires 30 June 2025 |
School age immunisations
| Diphtheria, Tetanus, and Polio – Td/IPV (Revaxis®) | V6.00 | From 4 August 2024 | Expires 6 December 2026 |
| Human Papilloma Virus – HPV (Gardasil®9) |
V6.00 | From 1 September 2023 | Expires 1 September 2025 |
| Meningitis A, C, W, and Y (Menveo®, Nimenrix® or MenQuadfi) |
V5.00 | From 31 July 2023 | Expires 31 July 2025 |
Adult immunisations
| Pertussis (pregnancy) – Diphtheria, Tetanus, Pertussis with/without Polio – Tdap or dTaP/IPV (ADACEL®, Boostrix-IPV® or Repevax®) |
V7.00 | From 1 July 2024 | Expires 1 July 2027 |
| Pneumococcal disease (Pneumovax® 23 (PPV)) |
V5.00 | From 1 September 2024 | Expires 1 March 2027 |
| Shingles – Herpes Zoster, recombinant, adjuvanted (Shingrix®) |
V2.00 | From 1 September 2023 | Expires 30 September 2025 |
| Respiratory Syncytial Virus (RSV (Abrysvo®) |
V1.00 | From 1 September 2024 | Expires 1 April 2027 |
Individuals at increased risk
Seasonal influenza
| Influenza – intranasal (Fluenz®) |
V14.00 | From 1 September 2024 | Expires 1 April 2025 |
| Influenza – intramuscular (various brands) |
V13.00 | From 1 September 2024 | Expires 1 April 2025 |
Coronavirus (Covid-19) vaccine
You can access Patient Group Directions (PGDs) for COVID-19 vaccines here.
National Protocols
New ‘national protocols’ have been introduced in response to the pandemic as legal mechanisms for administration of Covid-19 vaccine, and also influenza vaccine. These offer greater flexibility than a PGD by allowing tasks to be delegated to unregistered staff.
PGD templates available in Microsoft Word format
Please note that the Microsoft Word version of the PGD templates that all of these PGDs were authorised from are available here.
Emergency preparedness
Authorised emergency preparedness PGDs (e.g. for flu outbreaks in care homes) are available on request. Note that these would normally be authorised by the commissioner of the service so contact your CCG if necessary.